Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry

International Journal of Cardiology

Volumn 219, Issue , 2016, Pages 331-338

  Ciampi, Quirino ^a,b   Olivotto, Iacopo ^c   Gardini, Chiara ^c   Mori, Fabio ^c   Peteiro, Jesus ^d   Monserrat, Lorenzo ^d   Fernandez, Xusto ^d   Cortigiani, Lauro ^e   Rigo, Fausto ^f   Lopes, Luis Rocha ^g,h   Cruz, Ines ^g   Cotrim, Carlos ^h   Losi, Mariangela ⁱ   Betocchi, Sandro ⁱ   Beleslin, Branko ^j   Tesic, Milorad ^j   Dikic, Ana Djordjevic ^j   Lazzeroni, Ettore ^k   Lazzeroni, Davide ^k   Sicari, Rosa ^b   Picano, Eugenio ^b   more..

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF A CORUÑA   (Spain)

^e Civil Hospital   (Italy)

^f OSPEDALE DELL'ANGELO   (Italy)

^g HOSPITAL GARCIA DE ORTA   (Portugal)

^h UNIVERSITY OF LISBON   (Portugal)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j UNIVERSITY OF BELGRADE   (Serbia)

^k IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

more..

Author keywords

Hypertrophic cardiomyopathy; Stress echocardiography

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; VASODILATOR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE ISCHEMIA; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STRESS ECHOCARDIOGRAPHY; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CLINICAL TRIAL; DIAGNOSTIC IMAGING; EXERCISE TEST; INTERNATIONAL COOPERATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REGISTER;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 84975886069     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.06.044     Document Type: Article

References (42)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
2. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
3. P.M. Elliott, A. Anastasakis, M.A. Borger, M. Borggrefe, F. Cecchi, P. Charron, A.A. Hagege, A. Lafont, G. Limongelli, H. Mahrholdt, W.J. McKenna, J. Mogensen, P. Nihoyannopoulos, S. Nistri, P.G. Pieper, B. Pieske, C. Rapezzi, F.H. Rutten, C. Tillmanns, and H. Watkins 2014 European Society of cardiology Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology Eur. Heart J. 35 2014 2733 2779
4. M.S. Maron, I. Olivotto, A.G. Zenovich, M.S. Link, N.G. Pandian, J.T. Kuvin, S. Nistri, F. Cecchi, J.E. Udelson, and B.J. Maron Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239
5. V. JC Jr., O. SR, N. RA, T. AJ, and G. BJ Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction Am. Heart J. 156 2008 342 347
6. J. Peteiro, A. Bouzas-Mosquera, X. Fernandez, L. Monserrat, P. Pazos, R. Estevez-Loureiro, and et al. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy J. Am. Soc. Echocardiogr. 25 2012 182 189
7. E. Lazzeroni, E. Picano, C. Dodi, L. Morozzi, G.P. Chiriatti, C. Lu, and G. Botti Dipyridamole echocardiography for diagnosis of coexistent coronary artery disease in hypertrophic cardiomyopathy Am. J. Cardiol. 75 1995 810 813
8. L. Cortigiani, F. Rigo, S. Gherardi, M. Galderisi, R. Sicari, and E. Picano Prognostic implications of coronary flow reserve in left anterior descending coronary artery in hypertrophic cardiomyopathy Am. J. Cardiol. 102 2008 926 932
9. N. Cardim, M. Galderisi, T. Edvardsen, S. Plein, B.A. PopEuropean Society Cardiologyu, A. D'Andrea, O. Bruder, B. Cosyns, L. Davin, E. Donal, A. Freitas, G. Habib, A. Kitsiou, S.E. Petersen, S. Schroeder, P. Lancellotti, P. Camici, R. Dulgheru, A. Hagendorff, M. Lombardi, D. Muraru, and R. Sicari Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association Eur. Heart J. Cardiovasc. Imaging 16 2015 280
10. R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande, and et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur. Heart J. Cardiovasc. Imaging 16 2015 233 270
11. R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.U. Voigt, J.L. Zamorano, and on behalf of the European Association of Echocardiography Stress echocardiography expert consensus statement. European Association of Echocardiography (EAE) (a registered branch of the European Society of Cardiology) Eur. J. Echocardiogr. 9 2008 415 437
12. J.S. Shah, M.T. Esteban, R. Thaman, and et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy Heart 94 2008 1288 1294
13. M. Tesic, A. Djordjevic-Dikic, B. Beleslin, D. Trifunovic, V. Giga, J. Marinkovic, O. Petrovic, M. Petrovic, J. Stepanovic, M. Dobric, V. Vukcevic, G. Stankovic, P. Seferovic, M. Ostojic, and B. Vujisic-Tesic Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis J. Am. Soc. Echocardiogr. 26 2013 775 782
14. P. Lancellotti, P.A. Pellikka, W. Budts, F. Chaudry, E. Donal, R. Dulgheru, T. Edvarsen, M. Garbi, J.W. Ha, G. Kane, J. Kreeger, L. Mertens, P. Pibarot, E. Picano, T. Ryan, J. Tsutsui, and A. Varga Recommendations for the clinical use of stress echocardiography in non-ischemic heart disease: joint document of the European Association of Cardiovascular imaging and the American Society of Echocardiography Eur. Heart J. Cardiovasc. Imaging 2016
15. I. Olivotto, B.J. Maron, A. Montereggi, F. Mazzuoli, A. Dolara, and F. Cecchi Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 33 1999 2044 2051
16. E. Argulian, and F.A. Chaudhry Stress testing in patients with hypertrophic cardiomyopathy Prog. Cardiovasc. Dis. 54 2012 477 482
17. R. Miranda, C. Cotrim, N. Cardim, S. Almeida, L. Lopes, M.J. Loureiro, O. Simões, P. Cordeiro, P. Fazendas, I. João, and M. Carrageta Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy Cardiovasc. Ultrasound 6 2008 19
18. C. O′Mahony, F. Jichi, M. Pavlou, L. Monserrat, A. Anastasakis, C. Rapezzi, E. Biagini, J.R. Gimeno, G. Limongelli, W.J. McKenna, R.Z. Omar, and P.M. Elliott A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) Eur. Heart J. 35 2014 2010 2020
19. Q. Ciampi, S. Betocchi, R. Lombardi, M.A. Losi, F. Manganelli, G. Storto, F. Finizio, E. Pezzella, A. Cuocolo, and M. Chiariello Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 40 2002 278 284
20. N. Yoshida, H. Ikeda, T. Wada, A. Matsumoto, S. Maki, A. Muro, A. Shibata, and T. Imaizumi Exercise-induced abnormal blood pressure response are related to subendocardial ischemia in hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 32 1998 1938 1942
21. E. Lazzeroni, E. Picano, L. Morozzi, A.R. Maurizio, G. Palma, R. Ceriati, E. Iori, and A. Barilli Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy Circulation 96 1997 4268 4272
22. V. Dilsizian, R.O. Ronow, S.E. Epstein, and L. FananapaTir Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 22 1993 769 804
23. B.J. Maron, S.A. Casey, R.G. Hauser, and et al. Clinical course of hypertrophic cardiomyopathy with survival to advanced age J. Am. Coll. Cardiol. 42 2003 882 888
24. M.Y. Desai, A. Bhonsale, P. Patel, P. Naji, N.G. Smedira, M. Thamilarasan, B.W. Lytle, and H.M. Lever Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes JACC Cardiovasc. Imaging 7 2014 26 36
25. S. Nistri, I. Olivotto, M.S. Maron, C. Ferrantini, R. Coppini, C. Grifoni, K. Baldini, A. Sgalambro, F. Cecchi, and B.J. Maron β blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy Am. J. Cardiol. 110 2012 715 719
26. M.S. Maron, I. Olivotto, S. Betocchi, and et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N. Engl. J. Med. 348 2003 295 303
27. M. Yamada, P.M. Elliott, J.C. Kaski, K. Prasad, J.N. Gane, C.M. Lowe, Y. Doi, and W.J. Mckenna Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy Eur. Heart J. 19 1998 500 507
28. P. Camici, G. Chiriatti, R. Lorenzoni, R.C. Bellina, R. Gistri, G. Italiani, O. Parodi, P.A. Salvadori, N. Nista, L. Papi, and A. L'Abbate Coronary vasodilation is impaired in both hypertrophied and non-hypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography J. Am. Coll. Cardiol. 5 1991 879 886
29. K. Okeie, M. Shimizu, H. Yoshio, H. Ino, M. Yamaguchi, T. Matsuyama, T. Yasuda, J. Taki, and H. Mabuchi Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 36 2000 856 863
30. B.J. Maron, J.K. Wolfson, S.E. Epstein, and W.C. Roberts Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 8 1986 545 557
31. C. Basso, G. Thiene, D. Corrado, G. Buja, P. Melacini, and A. Nava Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia Hum. Pathol. 31 2000 988 998
32. B. Schwartzkopff, M. Mundhenke, and B. Strauer Alterations of the architecture of the subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia J. Am. Coll. Cardiol. 31 1998 1089 1096
33. S.A. Timmer, and P. Knaapen Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography Eur. Heart J. Cardiovasc. Imaging 14 2013 95 101
34. F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P.G. Camici Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N. Engl. J. Med. 349 2003 1027 1035
35. J. Taki, K. Nakajima, M. Shimizu, N. Tonami, and K. Hisada Left ventricular functional reserve in nononstructive hypertrophic cardiomyopathy: evaluation by continuous left ventricular function monitoring J. Nucl. Med. 35 1994 1937 1943
36. M.A. Losi, S. Betocchi, M. Aversa, R. Lombardi, M. Miranda, A. Cacace, Q. Ciampi, C.G. Tocchetti, A. Guida, and M. Chiariello Dobutamine stress echocardiography in hypertrophic cardiomyopathy Cardiology 100 2003 93 100
37. A. Nemes, E. Balázs, O.I. Soliman, R. Sepp, M. Csanády, and T. Forster Long-term prognostic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study Heart Vessel. 24 2009 352 356
38. I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P.G. Camici Relevance of coronary microvascular flow impairment to long-term remodelling and systolic dysfunction in hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 47 2006 1043 1048
39. P.E. Bravo, A. Pinheiro, T. Higuchi, C. Rischpler, J. Merrill, M. Santaularia-Tomas, M.R. Abraham, R.L. Wahl, T.P. Abraham, and F.M. Bengel PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy J. Nucl. Med. 53 2012 407 414
40. E. Picano, W. Mathias, A. Pingitore, R. Bigi, M. Previtali, and on behalf of the EDIC Study Group Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale multicenter trial Lancet 344 1994 1190 1192
41. E. Picano, P. Landi, L. Bolognese, G. Chiarandà, F. Chiarella, G. Seveso, M.G. Sclavo, N. Gandolfo, M. Previtali, and A. Orlandini Prognostic value of dipyridamole-echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group Am. J. Med. 11 1993 608 618
42. M.S. Lauer, E.H. Blackstone, J.B. Young, and E.J. Topol Cause of death in clinical research: time for a reassessment? JACC 34 1999 618 620